The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
294 - Hello, I have a piece that is being reviewed and will likely be available before my required date of 1st use. Is it possible to align the PAAB expiry with the timing of use of my piece.
-
Yes, if your piece is approved prior to your 'intended date of use', we can forward the start date of the acceptance period by a maximum of 3 months from the date of approval. Please advise PAAB of your intended date of use as part of your eFile submission or notify us during the active review process that this date has changed. Please find the link to our Submissions Guidance document and refer to the bottom of page 1 for additional information. http://www.paab.ca/resources/pdfs/code-revision/Guidance_on_Submission_Process.pdf
